首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   44922篇
  免费   3033篇
  国内免费   716篇
耳鼻咽喉   255篇
儿科学   1962篇
妇产科学   1255篇
基础医学   6022篇
口腔科学   1186篇
临床医学   3039篇
内科学   8824篇
皮肤病学   709篇
神经病学   3422篇
特种医学   1989篇
外国民族医学   5篇
外科学   6067篇
综合类   3156篇
预防医学   3126篇
眼科学   440篇
药学   4278篇
  25篇
中国医学   882篇
肿瘤学   2029篇
  2023年   585篇
  2022年   808篇
  2021年   1530篇
  2020年   1572篇
  2019年   2504篇
  2018年   2397篇
  2017年   1647篇
  2016年   1221篇
  2015年   1238篇
  2014年   2166篇
  2013年   2255篇
  2012年   1636篇
  2011年   1784篇
  2010年   1462篇
  2009年   1607篇
  2008年   1426篇
  2007年   1358篇
  2006年   1262篇
  2005年   1045篇
  2004年   934篇
  2003年   896篇
  2002年   678篇
  2001年   642篇
  2000年   569篇
  1999年   516篇
  1998年   407篇
  1997年   346篇
  1996年   274篇
  1995年   274篇
  1994年   235篇
  1993年   179篇
  1992年   160篇
  1991年   166篇
  1990年   137篇
  1989年   126篇
  1988年   125篇
  1987年   92篇
  1985年   1034篇
  1984年   1827篇
  1983年   1117篇
  1982年   1248篇
  1981年   1207篇
  1980年   994篇
  1979年   900篇
  1978年   805篇
  1977年   689篇
  1976年   792篇
  1975年   559篇
  1974年   496篇
  1973年   562篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
背景维生素D(VitD)是一种有效的免疫调节剂,其缺乏与支气管哮喘(以下简称哮喘)患者气道炎症、病情加重和预后不良有关。目前,成人哮喘与VitD相关性的研究报道较少,且研究结果并不一致。目的探讨成人哮喘患者血清25-羟维生素D〔25(OH)D〕水平与肺通气功能、最小诱发累积剂量(Dmin)的相关性。方法本研究为回顾性研究。选取新疆医科大学第一附属医院2020年1月至2021年9月收治的179例初诊哮喘患者作为观察组,另选取同期在新疆医科大学第一附属医院进行健康体检的151例健康体检者作为对照组。比较两组受试者血清25(OH)D水平,不同血清25(OH)D水平的哮喘患者肺通气功能指标〔用力肺活量(FVC)、FVC占预计值百分比、第1秒用力呼气容积(FEV1)、FEV1占预计值百分比、FEV1/FVC、FEV1/FVC占预计值百分比、呼气流量峰值(PEF)、PEF占预计值百分比及用力呼出25%肺活量的呼气流量(FEF25)、用力呼出50%肺活量的呼气流量(FEF50)、用力呼出75%肺活量的呼气流量(FEF75)、最大呼气中期流量(MMEF)占预计值百分比〕及Dmin;成人哮喘患者血清25(OH)D水平与Dmin的相关性分析采用Pearson相关分析。结果观察组患者血清25(OH)D水平低于对照组(P<0.05)。不同血清25(OH)D水平的哮喘患者FVC、FVC占预计值百分比、FEV1、FEV1占预计值百分比、FEV1/FVC、FEV1/FVC占预计值百分比、PEF、PEF占预计值百分比、FEF25占预计值百分比、FEF50占预计值百分比、FEF75占预计值百分比及MMEF占预计值百分比比较,差异无统计学意义(P>0.05);血清25(OH)D水平不足、缺乏的哮喘患者Dmin低于血清25(OH)D水平正常的哮喘患者,血清25(OH)D水平缺乏的哮喘患者Dmin低于血清25(OH)D水平不足的哮喘患者(P<0.05)。Pearson相关分析结果显示,成人哮喘患者血清25(OH)D水平与Dmin呈正相关(r=0.300,P<0.001)。结论血清25(OH)D水平与成人哮喘患者肺通气功能无关,但与Dmin呈正相关,故血清25(OH)D水平对评估成人哮喘患者气道高反应性(AHR)具有一定参考价值。  相似文献   
2.
目的 研究足月新生儿黄疸、维生素D(VD)水平及NADSYN1基因rs12785878位点单核苷酸多态性(SNP)间的关系。方法 回顾性分析216例患有黄疸的足月新生儿的临床资料,利用液相色谱-串联质谱法(LC-MS/MS)检测血清VD水平,高分辨熔解曲线(HRM)分析NADSYN1基因rs12785878位点SNP。以患儿是否>14 d分组并分别分析高胆红素血症的影响因素。结果 对于≤14 d患儿,感染、剖宫产、母乳喂养为高胆红素血症发生的危险因素;对于>14 d患儿,感染、低血浆蛋白为高胆红素血症发生的危险因素。建立的rs12785878位点HRM方法扩增反应良好,GG、GT、TT基因型区分明显。高胆组患儿携带GG基因型、G等位基因的比例更高。≤14 d患儿,TT基因型新生儿VD水平高于GG基因型新生儿[(12.61±5.23)μg/L vs.(9.62±4.24)μg/L,P<0.05]。结论 NADSYN1基因rs12785878位点GG基因型为高胆红素血症、≤14 d新生儿低VD水平的危险因素,可作为足月新生儿高胆红素血症诊治的新参考。  相似文献   
3.
《Saudi Pharmaceutical Journal》2022,30(10):1486-1496
IntroductionPreclinical studies have demonstrated the possible anticancer effects of statins, but the synergistic effect of concomitant statin use with standard chemotherapy protocols in patients with breast cancer has not yet been investigated.AimThe current study aimed to evaluate the efficacy of concomitant pitavastatin use with neoadjuvant chemotherapy protocols in patients with breast cancer.MethodsThis study was a randomized controlled clinical trial. A total of 70 adult female patients with pathologically-proven invasive breast cancer were randomized to receive or not receive pitavastatin (2 mg) oral tablets once daily concomitantly with standard neoadjuvant chemotherapy protocols for 6 months. The primary outcomes of this study were changes in tumor size and changes to the Ki67 index. In addition, secondary outcomes were changes in cyclin D1 and cleaved caspase-3 serum levels. This study was registered at ClinicalTrials.gov (Identifier: NCT04705909).ResultsPatients in the pitavastatin group showed significantly higher median (IQR) reductions in tumor size [?19.8 (?41.5, 9.5)] compared to those in the control group [?5.0 (?15.5, 0.0), p = 0.0009]. The change in Ki67 from baseline to the end of therapy was similar between the two groups (p = 0.12). By the end of therapy, the cyclin D1 levels in the pitavastatin group were significantly decreased [median (IQR) change of ? 10.0 (?20.2, ?2.9) from baseline], whereas the control group showed an increase in cyclin D1 levels [14.8 (4.1, 56.4)]. The median (IQR) caspase?3 was elevated in the pitavastatin group 1.6 (0.2, 2.2), and decreased in the control group (?0.2 (?1.1, 0.0), p = 0.0002).Subgroup analysis of the pitavastatin group revealed that patients with positive human epidermal growth receptor 2 (HER2) had higher median (IQR) reductions in Ki67 [?35.0 (?70.0, ?12.5)] than those with negative HER2 [2.5 (?15.0, 10.0), p = 0.04]. All patients who achieved a complete pathological response (n = 9) exhibited an HER2-neu positive receptor at baseline.ConclusionConcomitant use of pitavastatin with standard neoadjuvant chemotherapy protocols may improve neoadjuvant chemotherapy responses in patients with breast cancer.  相似文献   
4.
5.
BackgroundAbout 50% of Americans and 70% of US military service members (SMs) regularly use dietary supplements (DSs) and some are associated with adverse effects (AEs). SMs are more likely to use unsafe DSs than civilians.ObjectiveThe aim of this investigation was to examine the prevalence of, and factors associated with, AEs.DesignCross-sectional.ParticipantsA stratified random sample of 200,000 US SMs from the Air Force, Army, Marine Corps, and Navy were obtained from military workforce records. Eighteen percent (n = 26,681) of successfully contacted SMs (n = 146,365) volunteered to participate between December 2018 and August 2019. Participants completed a detailed online questionnaire on demographic characteristics, lifestyle factors, and AEs associated with DS use.Main outcome measurePrevalence of, and factors associated with, AEs among DS users.Statistical analysisPrevalence of AEs was calculated by DS categories. Linear trends, χ2 statistics, and multivariable logistic regression examined associations between AEs and demographic characteristics, lifestyle factors, and number DSs consumed.ResultsProportion of DS users (≥ 1 time /week) reporting ≥1 AE was 18% overall, 20% for combination products (ie, weight loss, muscle building, and before/after workout supplements), 8% for purported prohormones, 6% for protein/amino acid products, 6% for multivitamin/multiminerals, 6% for individual vitamins/minerals, 4% for herbal products, and 2% for joint health products. Combination products are very popular in military personnel with nearly half of SMs regularly taking them. In multivariable analysis, reporting AEs were independently associated with female gender, younger age, higher body mass index, smoking, higher alcohol intake, service in the Army, Navy, or Marine Corps (compared with Air Force), and consumption of a greater number of DSs.ConclusionsA large proportion of SMs report experiencing AEs, especially users of combination products and purported prohormone supplements. This study presents contemporary data collected from a very large at-risk population on potentially hazardous categories of DSs.  相似文献   
6.
《Immunobiology》2022,227(6):152298
PLPPs (Phospholipid phosphatases) are widely expressed in different human tissues, regulate cell signal transduction, and are overexpressed in cancers such as gliomas, pancreatic adenocarcinoma, lung adenocarcinoma, and so on. As a member of the PLPP family, PLPP2 (phospholipid phosphatase 2) plays a vital role in the occurrence and development of breast cancer, but its mechanism is still unclear. Our research found that PLPP2 was overexpressed in breast cancer, and the higher expression level of PLPP2 showed a worse prognosis for breast cancer patients. Further analysis showed that overexpression of PLPP2 affected the expression of CDC34 (cell-division cycle 34), LSM7 (Like-Smith 7), and SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha) through EMT (epigenetic-mesenchymal transition) related pathways to promote the occurrence and development of breast cancer. In vitro, silencing PLPP2 significantly reduced the proliferation, invasion, and migration abilities of human breast cancer cells MDA-MB-231. ER+ is a common subtype of breast cancer. Furthermore, we found that the overexpression of PLPP2 was significantly related to the poor prognosis of ER+ breast cancer. These results indicate that PLPP2 has value as a potential therapeutic target for breast cancer, especially for ER+ breast cancer.  相似文献   
7.
Defects of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein affect the homeostasis of chloride, bicarbonate, sodium, and water in the airway surface liquid, influencing the mucus composition and viscosity, which induces a severe condition of infection and inflammation along the whole life of CF patients. The introduction of CFTR modulators, novel drugs directly intervening to rescue the function of CFTR protein, opens a new era of experimental research. The review summarizes the most recent advancements to understand the characteristics of the infective and inflammatory pathology of CF lungs.  相似文献   
8.
儿童食物过敏发生率逐年增加,成为一个受到社会各界关注的重要健康问题。近期研究发现维生素D从胎儿时期即可影响人体免疫系统的调节作用,母体低水平的维生素D会增加子代过敏性疾病的风险。但目前国内外关于母体维生素D营养状态与子代食物过敏相关研究较少,为此本文就母体维生素D营养状态与子代食物过敏发生相关性进行综述。  相似文献   
9.
目的探究老年2型糖尿病(T2DM)并阻塞性睡眠呼吸暂停综合征(OSAS)患者25羟基维生素D[25(OH)D]和血小板参数[平均血小板体积(MPV)和血小板分布宽度(PDW)]变化及与OSAS严重程度的相关性。方法选择2016年10月—2021年10月于宁德师范学院附属宁德市医院诊治的61例老年T2DM合并OSAS患者为观察组,50例单纯T2DM患者为对照组。观察并比较2组基线资料及血25(OH)D、MPV、PDW水平,以及OSAS严重程度不同的患者25(OH)D、MPV和PDW水平,采用Logistic回归模型分析OSAS的影响因素。结果 2组BMI、高血压史、冠心病史、糖化血红蛋白(HbA1c)、高密度脂蛋白胆固醇(HDL-C)和尿酸(UA)差异具有统计学意义(P<0.05);观察组MPV和PDW显著高于对照组(P<0.05),25(OH)D低于对照组(P<0.05);OSAS严重程度不同的患者间25 (OH)D和血小板参数差异具有统计学意义(P<0.05),其中25(OH)D随着OSAS严重程度的增高而降低(P<0.05),MPV、PDW随着OSAS严重程度的增高而上升(P<0.05);Logistic回归分析结果显示,冠心病史、HbA1c、25(OH)D、MPV和PDW是OSAS发生的影响因素(P<0.05)。结论老年T2DM合并OSAS患者MPV和PDW变化呈现上升趋势,25(OH)D呈下降趋势,其水平变化与T2DM合并OSAS发生和病情关系密切。  相似文献   
10.
《Vaccine》2022,40(27):3737-3745
BackgroundVaccines may induce non-specific effects on survival and health outcomes, in addition to protection against targeted pathogens or disease. Observational evidence suggests that infant Baccillus Calmette-Guérin (BCG) vaccination may provide non-specific survival benefits, while diphtheria-tetanus-pertussis (DTP) vaccination may increase the risk of mortality. Non-specific vaccine effects have been hypothesized to modify the effect of neonatal vitamin A supplementation (NVAS) on mortality.Methods22,955 newborns in Ghana and 31,999 newborns in Tanzania were enrolled in two parallel, randomized, double-blind, placebo-controlled trials of neonatal vitamin A supplementation from 2010 to 2014 and followed until 1-year of age. Cox proportional hazard models were used to estimate associations of BCG and DTP vaccination with infant survival.ResultsBCG vaccination was associated with a decreased risk of infant mortality after controlling for confounders in both countries (Ghana adjusted hazard ratio (aHR): 0.51, 95% CI: 0.38–0.68; Tanzania aHR: 0.08, 95% CI: 0.07–0.10). Receiving a DTP vaccination was associated with a decreased risk of death (Ghana aHR: 0.39, 95% CI: 0.26–0.59; Tanzania aHR: 0.19, 95% CI: 0.16–0.22). There was no evidence of interaction between BCG or DTP vaccination status and infant sex or NVAS.ConclusionWe demonstrated that BCG and DTP vaccination were associated with decreased risk of infant mortality in Ghana and Tanzania with no evidence of interaction between DTP or BCG vaccination, NVAS, and infant sex. Our study supports global recommendations on BCG and DTP vaccination and programmatic efforts to ensure all children have access to timely vaccination.Clinical trials registration: Ghana (Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12610000582055) and Tanzania (ANZCTR: ACTRN12610000636055)  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号